GEM Co Ltd
GEM Co Ltd operates in the Specialty Chemicals industry within the Basic Materials sector, generating revenue through chemical manufacturing activities.
Business. GEM Co Ltd (002340.SZ) is a specialty chemicals company headquartered in China and listed on the Shenzhen Stock Exchange. The firm operates within the broader chemicals industry, focusing on the production and sale of chemical products. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
4 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
GEM Co Ltd (002340.SZ) is a specialty chemicals company headquartered in China and listed on the Shenzhen Stock Exchange. The firm operates within the broader chemicals industry, focusing on the production and sale of chemical products. Specific details regarding its operating segments and geographic revenue mix are not available.
GEM Co Ltd maintains a capital structure characterized by significant leverage, with a debt-to-equity ratio of 1.56 and long-term debt totaling 33.46 billion CNY against total equity of 21.38 billion CNY. Liquidity is tight, evidenced by a current ratio of 1.01, which suggests limited short-term buffer against operational fluctuations. The company reports negative free cash flow of -6.06 billion CNY, driven by substantial capital expenditures of 9.17 billion CNY that exceed operating cash flow of 3.78 billion CNY. This heavy investment phase results in a negative net cash position after accounting for total debt, indicating reliance on external financing or existing cash reserves to fund growth initiatives.
Profitability metrics indicate modest returns relative to the capital employed. The return on equity stands at 7.39%, while return on assets is 2.13%, reflecting the asset-intensive nature of the specialty chemicals business. The gross profit margin is approximately 14.3%, derived from gross profit of 5.32 billion CNY on revenue of 37.12 billion CNY. Operating income of 2.05 billion CNY yields an operating margin of roughly 5.5%, which is typical for capital-intensive manufacturing but leaves limited room for error in cost management. Net income of 1.58 billion CNY results in a net margin of approximately 4.3%.
Revenue concentration and segment details are not explicitly provided in the available data, preventing a detailed analysis of product mix or geographic exposure. The company’s total revenue of 37.12 billion CNY suggests a large-scale operation, but without segment breakdowns, the specific drivers of this revenue volume remain opaque. The absence of geographic data limits the assessment of regional risk factors or market-specific growth opportunities.
Growth trajectory analysis is constrained by the lack of historical period data in the input. The current revenue figure of 37.12 billion CNY serves as the baseline, but year-over-year trends cannot be established from the provided snapshot. The significant capital expenditure of 9.17 billion CNY implies an expectation of future revenue growth or capacity expansion, but the realization of this growth remains unverified by historical trends in the current dataset.
Risk factors include medium liquidity risk and low dilution risk. The key flag notes that net cash is negative after subtracting total debt, highlighting the company's leverage exposure. The tight current ratio of 1.01 further underscores liquidity constraints. While dilution risk is assessed as low, with basic and diluted shares outstanding being identical at 5.10 billion, the high debt load poses a credit risk if operating cash flows do not improve to service debt obligations.
Recent events and market sentiment reflect a cautious outlook. Analyst estimates show a mean price target of 8.47 CNY and a median of 8.85 CNY, suggesting potential upside from the current market price of 6.50 CNY. However, the mean recommendation of 2.75 indicates a neutral stance, with no strong buy ratings and only two buy ratings among the analysts covering the stock. The high price target of 9.80 CNY and low of 6.40 CNY show a wide dispersion in analyst expectations, reflecting uncertainty about the company's future performance.
- High leverage with a debt-to-equity ratio of 1.56 and negative free cash flow of -6.06 billion CNY due to heavy capital expenditures.
- Tight liquidity position with a current ratio of 1.01, indicating minimal short-term financial buffer.
- Modest profitability with a 7.39% ROE and 4.3% net margin, typical for capital-intensive specialty chemicals.
- Analyst sentiment is neutral with a mean recommendation of 2.75, though price targets suggest potential upside from current levels.
- Low dilution risk as basic and diluted shares outstanding are identical, but credit risk remains elevated due to high debt levels.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,39 |
| Revenue | —no estimate | —no estimate | 52,4B CNY |
| Operating income | —no estimate | —no estimate | 3,6B CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Ev To Revenueenterprise_value / revenue
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Return On Assetsnet_income / total_assets
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- GEM Co Ltd Market data — financials · 2026-07-09
- GEM Co Ltd Market data — analyst estimates · 2026-07-09
- GEM Co Ltd Market data — ESG · 2026-07-09